Assay Detail
Functional
CHEMBL2040413
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Cytostatic activity against human CEM/0 after 72 hrs by cell counting
10
Total Activities
10
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | CCRF-CEM |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Novel 1,2,4-triazole and imidazole derivatives of L-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 10 | 4.93 | 6.41 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL53463 | DOXORUBICIN | 4.0 | 1 | 6.41 |
| CHEMBL2369357 | — | — | 1 | 5.14 |
| CHEMBL2036521 | — | — | 1 | 5.00 |
| CHEMBL2036522 | — | — | 1 | 4.46 |
| CHEMBL2036518 | — | — | 1 | 4.36 |
| CHEMBL1643 | RIBAVIRIN | 4.0 | 1 | 4.20 |
| CHEMBL2036520 | — | — | 1 | - |
| CHEMBL2036519 | — | — | 1 | - |
| CHEMBL2036517 | — | — | 1 | - |
| CHEMBL2036523 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL53463 | DOXORUBICIN | IC50 | = | 390.0 | nM | 6.41 |
| CHEMBL2369357 | — | IC50 | = | 7300.0 | nM | 5.14 |
| CHEMBL2036521 | — | IC50 | = | 10000.0 | nM | 5.00 |
| CHEMBL2036522 | — | IC50 | = | 35000.0 | nM | 4.46 |
| CHEMBL2036518 | — | IC50 | = | 44000.0 | nM | 4.36 |
| CHEMBL1643 | RIBAVIRIN | IC50 | = | 63000.0 | nM | 4.20 |
| CHEMBL2036520 | — | IC50 | > | 500000.0 | nM | - |
| CHEMBL2036519 | — | IC50 | = | 445000.0 | nM | - |
| CHEMBL2036517 | — | IC50 | > | 100000.0 | nM | - |
| CHEMBL2036523 | — | IC50 | = | 154000.0 | nM | - |